Triple
T22717597
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Genzyme |
E561775
|
entity |
| Predicate | hasProduct |
P3585
|
FINISHED |
| Object | Renvela |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Renvela | Statement: [Genzyme, hasProduct, Renvela]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Renvela Context triple: [Genzyme, hasProduct, Renvela]
-
A.
Rinvoq
Rinvoq is a prescription JAK inhibitor medication used to treat various inflammatory and autoimmune conditions such as rheumatoid arthritis and atopic dermatitis.
-
B.
Andexxa
Andexxa is a recombinant modified human factor Xa protein used as a reversal agent to counteract the anticoagulant effects of factor Xa inhibitors such as rivaroxaban and apixaban.
-
C.
Atalide
Atalide is a central tragic heroine in Jean Racine’s 1672 play "Bajazet," caught in a complex web of love, jealousy, and political intrigue in the Ottoman court.
-
D.
Anpezan
Anpezan is a regional dialect of the Ladin language spoken in parts of the Dolomite area of northern Italy.
-
E.
Gilenya
Gilenya is an oral prescription medication used to treat relapsing forms of multiple sclerosis by modulating sphingosine-1-phosphate receptors to reduce immune attacks on the nervous system.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Renvela Target entity description: Renvela is a prescription phosphate binder used to control serum phosphorus levels in patients with chronic kidney disease on dialysis.
-
A.
Rinvoq
Rinvoq is a prescription JAK inhibitor medication used to treat various inflammatory and autoimmune conditions such as rheumatoid arthritis and atopic dermatitis.
-
B.
Andexxa
Andexxa is a recombinant modified human factor Xa protein used as a reversal agent to counteract the anticoagulant effects of factor Xa inhibitors such as rivaroxaban and apixaban.
-
C.
Atalide
Atalide is a central tragic heroine in Jean Racine’s 1672 play "Bajazet," caught in a complex web of love, jealousy, and political intrigue in the Ottoman court.
-
D.
Anpezan
Anpezan is a regional dialect of the Ladin language spoken in parts of the Dolomite area of northern Italy.
-
E.
Gilenya
Gilenya is an oral prescription medication used to treat relapsing forms of multiple sclerosis by modulating sphingosine-1-phosphate receptors to reduce immune attacks on the nervous system.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2454fc984819088213b58ee87a002 |
completed | April 17, 2026, 2:35 p.m. |
| NER | Named-entity recognition | batch_69f1790ecbc48190926d16b20b674dbd |
completed | April 29, 2026, 3:20 a.m. |
Created at: April 17, 2026, 3:19 p.m.